ID   CLM8_RAT                Reviewed;         310 AA.
AC   A2TGX5;
DT   26-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   06-MAR-2007, sequence version 1.
DT   24-JUL-2024, entry version 83.
DE   RecName: Full=CMRF35-like molecule 8;
DE            Short=CLM-8;
DE   AltName: Full=CD300 antigen-like family member A;
DE   AltName: CD_antigen=CD300a;
DE   Flags: Precursor;
GN   Name=Cd300a;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar;
RA   Martinez-Barriocanal A., Peluffo H., Sayos J.;
RT   "Cloning of the rat ortholog of the inhibitory receptor CD300a.";
RL   Submitted (DEC-2006) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Inhibitory receptor which may contribute to the down-
CC       regulation of cytolytic activity in natural killer (NK) cells, and to
CC       the down-regulation of mast cell degranulation. Negatively regulates
CC       the Toll-like receptor (TLR) signaling mediated by MYD88 but not TRIF
CC       through activation of PTPN6. {ECO:0000250|UniProtKB:Q9UGN4}.
CC   -!- SUBUNIT: Upon tyrosine-phosphorylation, interacts with PTN6/SHP-1 and
CC       PTPN11/SHP-2 and INPP5D. {ECO:0000250|UniProtKB:Q6SJQ0}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q6SJQ0};
CC       Single-pass type I membrane protein {ECO:0000250|UniProtKB:Q6SJQ0}.
CC   -!- PTM: Phosphorylated on tyrosine. {ECO:0000250|UniProtKB:Q6SJQ0}.
CC   -!- PTM: N-glycosylated. {ECO:0000250|UniProtKB:Q6SJQ0}.
CC   -!- SIMILARITY: Belongs to the CD300 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EF199812; ABM90425.1; -; mRNA.
DR   AlphaFoldDB; A2TGX5; -.
DR   SMR; A2TGX5; -.
DR   STRING; 10116.ENSRNOP00000072406; -.
DR   GlyCosmos; A2TGX5; 3 sites, No reported glycans.
DR   GlyGen; A2TGX5; 3 sites.
DR   PhosphoSitePlus; A2TGX5; -.
DR   PeptideAtlas; A2TGX5; -.
DR   AGR; RGD:1583719; -.
DR   RGD; 1583719; Cd300a.
DR   InParanoid; A2TGX5; -.
DR   PhylomeDB; A2TGX5; -.
DR   Reactome; R-RNO-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   PRO; PR:A2TGX5; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0019902; F:phosphatase binding; ISO:RGD.
DR   GO; GO:0008429; F:phosphatidylethanolamine binding; ISO:RGD.
DR   GO; GO:0001786; F:phosphatidylserine binding; ISO:RGD.
DR   GO; GO:0038023; F:signaling receptor activity; ISO:RGD.
DR   GO; GO:0051649; P:establishment of localization in cell; ISO:RGD.
DR   GO; GO:0043303; P:mast cell degranulation; ISO:RGD.
DR   GO; GO:0030889; P:negative regulation of B cell proliferation; ISO:RGD.
DR   GO; GO:0050859; P:negative regulation of B cell receptor signaling pathway; ISO:RGD.
DR   GO; GO:1902567; P:negative regulation of eosinophil activation; ISO:RGD.
DR   GO; GO:2000417; P:negative regulation of eosinophil migration; ISO:RGD.
DR   GO; GO:0048147; P:negative regulation of fibroblast proliferation; ISO:RGD.
DR   GO; GO:0033007; P:negative regulation of mast cell activation involved in immune response; ISO:RGD.
DR   GO; GO:0043305; P:negative regulation of mast cell degranulation; ISO:RGD.
DR   GO; GO:0034125; P:negative regulation of MyD88-dependent toll-like receptor signaling pathway; ISO:RGD.
DR   GO; GO:1902564; P:negative regulation of neutrophil activation; ISO:RGD.
DR   GO; GO:0051134; P:negative regulation of NK T cell activation; ISO:RGD.
DR   GO; GO:0060101; P:negative regulation of phagocytosis, engulfment; ISO:RGD.
DR   GO; GO:0014063; P:negative regulation of serotonin secretion; ISO:RGD.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; ISO:RGD.
DR   GO; GO:0050856; P:regulation of T cell receptor signaling pathway; ISO:RGD.
DR   GO; GO:0001820; P:serotonin secretion; ISO:RGD.
DR   GO; GO:0002552; P:serotonin secretion by mast cell; ISO:RGD.
DR   CDD; cd05716; IgV_pIgR_like; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 1.
DR   InterPro; IPR050671; CD300_family_receptors.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR013106; Ig_V-set.
DR   PANTHER; PTHR11860:SF116; CMRF35-LIKE MOLECULE 8; 1.
DR   PANTHER; PTHR11860; POLYMERIC-IMMUNOGLOBULIN RECEPTOR; 1.
DR   Pfam; PF15330; SIT; 1.
DR   Pfam; PF07686; V-set; 1.
DR   SMART; SM00409; IG; 1.
DR   SUPFAM; SSF48726; Immunoglobulin; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane; Disulfide bond; Glycoprotein; Immunity;
KW   Immunoglobulin domain; Membrane; Phosphoprotein; Receptor;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000255"
FT   CHAIN           27..310
FT                   /note="CMRF35-like molecule 8"
FT                   /id="PRO_0000320133"
FT   TOPO_DOM        27..178
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        179..199
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        200..310
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          27..128
FT                   /note="Ig-like V-type"
FT   REGION          136..168
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          271..310
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        136..160
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        271..292
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        293..310
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         295
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6SJQ0"
FT   CARBOHYD        42
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        92
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        101
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        45..112
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
SQ   SEQUENCE   310 AA;  34495 MW;  8761E70FF6BD8360 CRC64;
     MTQLASAVWP PTLLLLLLFW VPGCVPLRGP SSVTGTVGES LNVTCQYEER FKMNKKYWCR
     GSLVLLCKDI VRTGGSEEAR NGRVSIRDDR DNLTFTVTLQ NLTLEDAGTY MCAVDIPLID
     HSFKVELSVV PGNIPVSSPG TTRETTVVPT SFSTKGPTQG SIPEGHHEHY EPQGLSLPVL
     LSVLALLLLL LVGTSLLAWR MFQKRSVKAD KHPEMSQNLR QAEEQSESQY VNLQLHTLPL
     REEPVPPSQV EVEYSTLALP QEELHYTSVV FDSQRQNSHA NGDPPCQSPD QKTEYSEIRK
     PREGLSDPHP
//
